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Fatigue and quality of life in women treated for various types of
gynaecological cancers: a cross-sectional study
Ragnhild Johanne Tveit Sekse, Karl Ove Hufthammer and Margrethe Elin Vika
Aims and objectives. To examine the prevalence of cancer-related fatigue in women
treated for various types of gynaecological cancers and, for these cancers, to assess
fatigue in relation to distress, health-related quality of life, demography and
treatment characteristics.
Background. Advances in treatment of cancer have improved the likelihood of survival.
Consequently, there are a growing number of patients who become survivors after can-
cer and who face side effects even years after treatment. One of the most frequently
reported side effects across all types and stages of the disease is cancer-related fatigue.
Design. A descriptive cross-sectional study.
Methods. One hundred and twenty women treated for gynaecological cancers who
were participants in an intervention study were included. Fatigue, psychological
distress, health-related QoL and demographics were assessed by questionnaires.
Disease and treatment characteristics were extracted from medical records.
Results. Cancer-related fatigue was reported in 53% of the women treated for gynaeco-
logical cancers, with a higher proportion in the group of cervical cancer, followed by
ovarian cancer. Younger participants reported fatigue more frequently than older partic-
ipants. When adjusting for age, the type of cancer a woman experiences was shown to
have little impact on her risk of experiencing fatigue. The participants with fatigue
reported higher levels of anxiety and depression than participants without fatigue. There
was a relationship between fatigue and quality of life as measured by SF-36 domains.
Conclusion. The findings underscore the importance of screening for fatigue,
patient education and symptom management. This should be included in a standard
procedure during treatment and follow-up. Both somatic and psychological aspects
of fatigue should be emphasised.
Relevance to clinical practice. The findings imply the need for health personnel to have
focus on fatigue during the entire cancer trajectory of women after gynaecological can-
cers, as well as the need for screening, information, guidance and symptom management.
Key words: anxiety, depression, fatigue, gynaecological cancers, quality of life
What does this study contribute to
the wider global clinical
community?
• Fatigue is highly prevalent
among all gynaecological cancer
types and treatment modalities.
• Younger women report fatigue
more frequently than older
women.
• Fatigued women report more
anxiety and depression and
poorer QoL.
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Introduction
Advances in treatment of cancer have improved the likeli-
hood of survival. Consequently, there are a growing num-
ber of patients who become survivors after cancer and who
face side effects even years after treatment. One of the most
frequently reported side effects across all types and stages
of the disease is cancer-related fatigue (Ahlberg et al. 2003,
Hofman et al. 2007, Stone & Minton 2008). Fatigue is
often explained as an experience of tiredness or exhaustion,
and approximately one-third of the patients continue to
experience cancer-related fatigue months and years after the
completion of treatment (Hofman et al. 2007).
Background
Cancer-related fatigue is a common symptom in women
treated for gynaecological cancers (Ferrell et al. 2003,
Liavaag et al. 2007, Vistad et al. 2007, Steele & Fitch
2008, Arriba et al. 2010, Harrington et al. 2010). Steele
and Fitch (2008) identified supportive care needs of women
diagnosed for various types of gynaecological cancers post-
diagnosis. The findings showed that fatigue was the fourth
most experienced issue (n = 103). This is also in line with a
descriptive study by Beesley et al. (2008), who found fati-
gue as a fourth ranged unmet support need in 802 women
following gynaecological cancer. Furthermore, in a review
by Harrington et al. (2010), the symptom burden most
commonly reported following primary treatment for cancer
(in survivors of breast, gynaecological, prostate and colo-
rectal cancer) was fatigue. Fatigue was found in 17–33% of
gynaecological cancer survivors three to eight years after
diagnosis.
Fatigue highly affects health-related QoL, as patients
with cancer may become too tired to fully participate in
daily life and activities, and to fill the roles they previously
had. Liavaag et al. (2007) conducted a controlled cross-
sectional study to explore fatigue, quality of life and
somatic and mental morbidity in ovarian cancer survivors.
In the study, 22% reported chronic fatigue, compared with
12% of the controls from the general population. The fati-
gued reported significantly more somatic disease and com-
plaints, higher scores on anxiety and lower levels of QoL
compared with norm samples. The study found minimal
differences between women with and without relapse, long
or short follow-up time and prognostic index status. Vistad
et al. (2007) found in a cross-sectional study of cervical
cancer survivors (n = 79) treated with radiotherapy that
30% of the women reported cancer-related fatigue (mean
follow-up time 79 years). Holzner et al. (2003) found in a
cross-sectional study that among 98 patients with ovarian
cancer (mean follow-up time 57 years), 33% reported fati-
gue. This group of patients had a significantly lower QoL
and higher scores on anxiety and depression.
Although specific studies on fatigue and the association
between different treatment modalities are lacking, there is
evidence of an association between multiple therapy and
impaired QoL and fatigue (Carlsson et al. 2000, Ahlberg
et al. 2005, Frumovitz et al. 2005, Korfage et al. 2009,
Bjelic-Radisic et al. 2012). Bjelic-Radisic et al.’s (2012)
study shows that patients with cervical cancer treated with
multiple therapy reported more impairments in their QoL
than those treated with only one therapy. Korfage et al.
(2009) found, among 291 cervical cancer survivors
2–10 years postdiagnosis, that radiotherapy was associated
with more treatment-related side effects. Ahlberg et al.
(2005) showed in their study that among women with uter-
ine cancer who received radiation therapy, fatigue scores
increased significantly during and after radiotherapy, com-
pared with pretreatment scores. Carlsson et al. (2000)
showed that patients who had been treated with chemo-
therapy had lower role and cognitive functioning and more
problems with, for example, fatigue. However, Liavaag
et al. (2008) found no significant differences regarding fati-
gue and QoL and treatment modalities.
A few studies have illuminated the relationship between
fatigue and psychological distress (Brown & Kroenke 2009,
Oh & Seo 2011). The review by Brown and Kroenke
(2009) included 59 studies and assessed evidence regarding
associations of cancer-related fatigue with depression and
anxiety. They confirmed these associations. In addition, a
literature review and meta-analysis by Oh and Seo con-
firmed those results (2011). These findings highlight the
importance of dealing with psychological distress and
symptom distress in relation to cancer-related fatigue. This
is also in line with Vistad et al. (2007), who found that the
women treated for cervical cancer who reported cancer-
related fatigue had significantly lower QoL, higher levels of
anxiety and depression, and more physical impairments.
For women diagnosed with different gynaecological cancers
and with different treatment modalities, few descriptions of
symptom experience like fatigue and QoL are available. As
fatigue has a major impact on women’s lives and well-
being, a clearer understanding of the effect of fatigue on
QoL in these gynaecological cancer groups is needed.
The primary aim of this study was to examine the preva-
lence of cancer-related fatigue in women treated for differ-
ent gynaecological cancers and, for these cancers, to assess
fatigue in relation to anxiety, depression, health-related
QoL, demography and treatment characteristics.
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Methods
Patients
The women in this study were participants in a randomised
controlled study. The purpose of the latter was to measure
and compare the effects of two interventions on women’s
self-reported quality of life and coping, namely an educa-
tional and counselling group versus a physical training
group. The study was carried out between 2009 and 2012.
The participants were recruited from three different hospi-
tals in Norway, using mailed letters. Inclusion criteria were
the following: (1) women finished with treatment for cura-
tive purpose of gynaecological cancers; (2) age > 18 years;
(3) specific physical functioning (able to walk on a tread-
mill); (4) no significant amnesic symptoms; and (5) agree-
ment to participate, as specified by consent form.
An invitation to participate in this study was sent to all
women treated for gynaecological cancer at all three hospi-
tals, thus fulfilling the inclusion criteria 1 and 2. The
women who wished to participate needed to return a con-
sent letter. One hospital invited women treated during the
period 2009–2011, and two hospitals invited those treated
in 2011–2012. Six hundred and twenty invitations were
sent.
Measures and questionnaires
The women were assessed using psychometric instruments
measuring fatigue, anxiety and depression, health-related
QoL, coping, sexuality, socio-demographic characteristics
(age, level of education, marital status, household status,
employment status, etc.) and treatment characteristics.
Workability was explored with the single question ‘Has
managing your job become more difficult after you returned
from sick leave compared to the time before you got sick’,
with the following response categories: ‘Yes’, ‘No’ and
‘Don’t know’. Details regarding diagnosis and treatment
were retrieved from the patient’s medical records. Data
related to physical activity were retrieved with a single
question: ‘Not including office hours, how many times a
week do you exercise to such a degree that you are sweat-
ing or need to catch your breath?’ The response categories
were the following: ‘Seven times or more’, ‘4–6 times a
week’, ‘2–3 times a week’, ‘Once a week’, ‘Once a month
or less’ and ‘Never’.
The Fatigue Questionnaire (FQ) (Chalder et al. 1993) is
validated and has 11 items concerning the fatigue intensity
women have felt during the last month compared with the
latest well-being. We used a Norwegian translation of a
modified version (Cella & Chalder 2010) of the FQ. This
translation has also been used in two Norwegian studies on
gynaecological cancer survivors (Liavaag et al. 2007, Vistad
et al. 2007) and in a large population survey in a general
Norwegian sample (Loge et al. 1998a).
Each item has four choice alternatives on an ordinal
response scale (0, 1, 2 or 3). Higher scores imply more fati-
gue. The wording in the response choices for 0 and 1 for
some of the items in the Norwegian version differs slightly
from those in the English version, which makes using the
Likert scoring described in Cella and Chalder (2010) prob-
lematic. We have therefore used the recommended bimodal
scoring system, where fatigue is identified according to the
procedure described in Cella and Chalder (2010): for each
woman, the number of items with the response 2 (‘more
than usual’) or 3 (‘much more than usual’) is counted, and
a count of four or more such responses is defined as indi-
cating fatigue.
The Hospital Anxiety and Depression Scale (HADS) (Zig-
mond & Snaith 1983) is often used to assess symptoms of
anxiety and depression in a nonpsychiatric context. It has
been widely used in Norwegian studies examining cancer
populations, including gynaecological cancer (Liavaag et al.
2009). HADS is a self-report questionnaire comprising
four-point ordinal response items (0, 1, 2 or 3): seven items
for anxiety (HADS-A) and seven items for depression
(HADS-D). Higher scores reflect higher symptom loads on
both subscales. Cases of HADS-defined anxiety disorder
(HADS-A) or depression (HADS-D) are defined by a score
of 8 or greater on the subscales. HADS has shown both
good reliability and validity in measuring levels of anxiety
and depression in primary care and in clinical populations
(Bjelland et al. 2002).
SF-36 is a multidomain self-report generic health mea-
sure assessing general health perception (Ware &
Sherbourne 1992). It is not disease, age or treatment
specific and is widely used to compare study samples from
the general population. The Physical health domain com-
prises physical functioning (10 items), physical role limita-
tions (four items), bodily pain (two items) and general
health (five items). The Mental health domain comprises
scales for energy/vitality (four items), social functioning
(two items), emotional role limitations (three items) and
mental health (five items). The psychometric properties are
well documented, also in Norwegian populations (Loge
et al. 1998a,b). The questionnaire’s response options vary
from yes/no to answers on a 3-, 5- or 6-point ordinal
response scale. The scores of the eight dimensions were
transformed into scales from 0 (poorest/worst health) to
100 (best health).
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Ethics
The study was approved by the Regional Committee for
Medical Research Ethics (2009/895). Each woman gave
written informed consent.
Data handling and statistics
The data were analysed using SPSS version 19.0 (Chicago,
IL, USA) and R 3.0.0 and 3.0.2 (R Core Team 2013). Cate-
gorical data were analysed using cross-tabulation and Fish-
er’s exact test. Continuous data were compared using
Welch’s two-sample t-test and reported with 95% confi-
dence intervals. Logistic regression analysis was used to
explore the association between caseness of chronic fatigue
(dependent variable) and various explanatory variables. The
results are reported as odds ratios with 95% confidence
intervals, along with p-values.
Results
Patient characteristics
A total of 120 women (mean age 56) with different types
of gynaecological cancers answered the questionnaires. Dis-
tribution of socio-demographic and disease characteristics
of the sample is shown in Table 1. Most of the women
(78%) were married or cohabiting. Almost all the women
(88%) had finished high school or university/college. While
26% of the women were retired, half of the women (52%)
were employed, and 5% were disabled.
Diagnosis and treatment characteristics
The participants were on average 16 months post-treatment,
and there was no relationship between fatigue and time
post-treatment, measured either using a t-test of time post-
diagnosis against caseness of fatigue (mean difference
19 months, p = 025) or by Kendall’s tau (s = 010,
p = 013) on time and fatigue score. The majority (93%)
were treated with surgery; 49% had received chemother-
apy, and 16% had received radiation. Two-thirds (69%)
had been diagnosed with early stage (FIGO stage I) disease.
As shown in Table 1, 46% of the women (n = 54, mean
age 61) were diagnosed with uterine cancer. These women
were mainly treated with surgery, and 28% had addition-
ally received chemotherapy, whereas only 8% had received
radiation. Most (80%) were diagnosed in FIGO stage I.
Twenty-seven per cent (n = 32, mean age 57) of the
women were treated for ovarian cancer. All were treated
with surgery, and most of them (81%) were treated with
adjuvant chemotherapy, while only one person received
radiation. About half (47%) were diagnosed in FIGO
stage I.
One-quarter (25%) (n = 29, mean age 47) were diag-
nosed with cervical cancer. Seventy-five per cent were
diagnosed in stage I of the disease, and 76% of the
women had been treated with surgery. About 52% of the
women had been treated with chemotherapy, and 45%
had received radiotherapy. There were significantly more
women treated for cervical cancer who received radiation
compared to uterine and ovarian cancer (Fisher’s exact
test: p < 0001).
Three women (3%) were diagnosed with vulval cancer
(mean age 55). One was diagnosed in stage I. All were trea-
ted with surgery, one was treated with radiation and one
with chemotherapy.
Variables associated with fatigue
Socio-demography
Women with fatigue were on average eight years younger
than nonfatigued women (95% CI: 32–121, p < 0001).
They also reported statistically significantly higher income
as compared to the nonfatigued women (p = 002).
There were no statistically significant differences in case-
ness of fatigue according to socio-demographic variables,
such as marital status, educational level or employment
status.
Diagnosis and treatment
The distribution of participants reporting fatigue or nonfa-
tigue according to diagnosis and treatment-related variables
is shown in Table 1. A total of 53% of the women
reported cancer-related fatigue. There were statistically sig-
nificant differences in reports of fatigue according to the
diagnosis (Fisher’s exact test, p = 004), with the highest
proportion of fatigue among women with cervical (69%)
and ovarian cancer (62%).
There were no differences in caseness of fatigue accord-
ing to treatment (surgery, radiation, chemotherapy) (all
p-values > 027) or in relation to time since diagnosis
(p = 031) or FIGO stage (p = 015).
Quality of life
As shown in Table 2, there were differences in all of the
eight domains in SF-36, with fatigued women reporting on
average lower levels of quality of life. Figure 1 displays the
detailed score distributions on the eight domains. Due to an
administrative error, some response forms were missing
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some of the SF-36 items. This explains the low number of
responses on one of the sum scales, but it has no effect on
the interpretation of the results (as all the differences are
statistically significant, and most of them are highly signifi-
cant).
Anxiety and depression
As shown in Table 3, the total mean sum scores of HADS
were 59 points (95% CI: 39–80, p < 0001) higher in
women reporting fatigue. The women had a higher score
on both subscales of HADS (both p-values < 0001).
Almost all of the women (14/15, 94%) with depression
(HADS-D score ≥ 8) reported fatigue, and a majority (21/
27, 78%) of the women with anxiety (HADS-A score ≥ 8)
also reported fatigue.
Exercise
There were statistically significant differences in the number
of weekly exercises, where nonfatigued women reported to
exercise more frequently (p = 003); see Table 1.
Table 1 Distribution of patient characteristics and treatment-related factors in fatigued and nonfatigued gynaecological cancers survivors
Nonfatigued (n = 56) Fatigued (n = 64) p-value Total sample (n = 120)
Age at survey time mean, SD (95% CI) 61, 12 (574–638) 53, 12 (498–560) <0001 56, 13 (542–588)
Civil status, n (%)
Paired relation 44 (80) 49 (77)
068
93 (78)
Single 5 (9) 5 (8) 10 (8)
Divorced 2 (4) 6 (9) 8 (7)
Widow 4 (7) 4 (6) 8 (7)
Regular physical activity, n (%)
7 times a week or more 4 (7) 2 (3)
003
6 (5)
4–6 times a week 11 (20) 12 (19) 23 (20)
2–3 times a week 26 (48) 16 (26) 42 (36)
Once a week 8 (15) 21 (34) 29 (25)
Less than once a week 5 (9) 11 (18) 16 (14)
Employment status, n (%)
Employed 24 (43) 38 (59)
009
62 (52)
Retired 21 (38) 10 (16) 31 (26)
Unemployed 6 (11) 8 (12) 14 (12)
Disability pension 3 (5) 3 (5) 6 (5)
Housewife 2 (4) 3 (5) 5 (4)
Other 0 (0) 2 (3) 2 (2)
Time from diagnosis to survey (months)
mean, SD (95% CI)
174, 85 (151–197) 155, 96 (130–176) 025 163, 91 (147–180)
Diagnosis, n (%)
Uterine 32 (58) 22 (35)
004
54 (46)
Ovarian 12 (22) 20 (32) 32 (27)
Cervical 9 (16) 20 (32) 29 (25)
Vulva 2 (4) 1 (2) 3 (3)
FIGO stage, n (%)
I 42 (78) 36 (61)
015
78 (69)
II 4 (7) 8 (14) 12 (11)
III 6 (11) 14 (24) 20 (18)
IV 2 (4) 1 (2) 3 (3)
Educational level, n (%)
Elementary school 8 (15) 6 (9)
071
14 (12)
Secondary school 23 (42) 29 (45) 52 (44)
College/university 24 (44) 29 (45) 53 (45)
Treatment modalities, n (%)
Surgery only 30 (55) 26 (42)
063
56 (48)
Surgery and chemotherapy 18 (33) 22 (35) 40 (34)
Surgery, chemotherapy and radiation 4 (7) 5 (8) 9 (8)
Chemotherapy and radiation 2 (4) 4 (6) 6 (5)
Surgery and radiation 1 (2) 3 (5) 4 (3)
Chemotherapy only 0 (0) 2 (3) 2 (2)
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Capacity for work
A total of 41% of the women in paid work reported that it
was harder to perform the same job after returning from
sick leave than before they became ill, whereas the fatigued
were more negatively affected compared with the nonfa-
tigued (p < 0001). Approximately 26% reported that they
had reduced their working hours because of the disease,
and 18% had received work accommodation because of the
illness. However, there were no significant differences in
reports of having reduced capacity for work according to
fatigue.
Logistic regression
When adjusted for age or for age and HADS in a logistic
model, the association between fatigue and diagnosis disap-
peared; see Table 4. This indicates that the type of cancer
matters little in determining whether a woman will experi-
ence fatigue, and the apparent association is mainly a result
of different types of cancers occurring for women in differ-
ent age groups. However, this does not imply that (younger)
age is a causal mechanism in fatigue. All the women
had experienced cancer and cancer treatment, which is
Table 2 Mean values and differences for the self-report scale SF-36 in fatigued and nonfatigued gynaecological patients with cancer. Positive
differences indicate worse health for women with fatigue.
Nonfatigued
Mean, SD, n (95% CI)
Fatigued
Mean, SD, n (95% CI) p-value Difference (95% CI)
Physical function 89, 12, 56 (85–92) 83, 15, 63 (79–87) 002 6 (09–106)
Role physical 81, 34, 56 (72–90) 48, 40, 61 (38–58) <0001 33 (192–462)
Bodily pain 81, 24, 56 (74–87) 71, 27, 64 (64–78) 004 10 (04–187)
General health 80, 16, 42 (75–85) 68, 20, 47 (62–74) 0002 12 (43–193)
Vitality 70, 17, 55 (65–74) 43, 19, 64 (39–48) <0001 27 (203–331)
Social function 94, 15, 56 (90–98) 74, 22, 64 (68–79) <0001 20 (134–268)
Role emotional 91, 22, 56 (85–97) 62, 39, 61 (52–72) <0001 29 (178–409)
Mental health 84, 12, 55 (81–87) 68, 18, 64 (64–72) <0001 16 (105–215)
Score
Non-fatigued
Fatigued
Physical function
0 20 40 60 80 100
Role physical Bodily pain
0 20 40 60 80 100
General health
Non-fatigued
Fatigued
0 20 40 60 80 100
Vitality Social function
0 20 40 60 80 100
Role emotional Mental health
Figure 1 Dot plot (strip chart) showing scores
on the eight quality of life domains of the
self-report scale SF-36 in fatigued and nonfa-
tigued gynaecological patients with cancer.
Higher values indicate better quality of life.
The dots have been slightly jittered vertically
to reduce the effect of overplotting.
Table 3 Mean values and differences for the self-report scale Hospital Anxiety and Depression Scale (HADS) in fatigued and nonfatigued
gynaecological patients with cancer. Positive differences indicate more anxiety/depression for women with fatigue.
Nonfatigued
Mean, SD, n (95% CI)
Fatigued
Mean, SD, n (95% CI) p-value Difference (95% CI)
HADS anxiety 35, 29, 56 (28–43) 64, 36, 63 (73–55) <0001 29 (17–40)
HADS depression 16, 2, 56 (10–21) 47, 37, 64 (56–37) <0001 31 (21–42)
HADS total 51, 44, 56 (39–63) 11, 69, 63 (127–93) <0001 59 (39–8)
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undoubtedly the main cause of the fatigue. But for a woman
of a given age, the type of cancer she has cannot be used to
predict whether she will experience post-treatment fatigue.
Discussion
The main findings in this study show that 53% of the
women reported cancer-related fatigue following gynaeco-
logical cancers. This is a higher percentage than in compara-
ble studies on gynaecological cancers, reporting a prevalence
from 17–33% over the different cancer types (Holzner et al.
2003, Liavaag et al. 2007, Vistad et al. 2007, Harrington
et al. 2010). This difference in prevalence may partly be
explained by differences in time from treatment to follow-
up. In the present study, we had a relatively short follow-up
time (mean 16 months). However, for our sample of
patients, we found no association between follow-up time
and fatigue, and we hypothesise that the reduction in preva-
lence of fatigue levels off slowly, over many years.
There were significant differences related to fatigue
between the groups of gynaecological cancers, with women
treated for cervical and ovarian cancer having the highest
proportion of fatigue. At first glance, one might think that
this makes sense due to the fact that women with cervical
and ovarian cancer receive radiation and/or chemotherapy,
thus leading to a strong impact on QoL and cancer-related
fatigue (Carlsson et al. 2000, Chan et al. 2001, Jereczek-
Fossa et al. 2002, Payne 2002, Greimel et al. 2009,
Goncalves 2010, Bjelic-Radisic et al. 2012). However,
when adjusting for age, the association between fatigue and
diagnosis disappears (while adjusting for diagnosis, there is
still a significant association between fatigue and age). Fur-
thermore, while age is associated with diagnosis, there is
considerable overlap in age for women with different can-
cers. All this indicates that for a woman of a given age, the
type of cancer she experiences has little impact on her risk
of experiencing fatigue.
Our study shows that younger women report fatigue and
poorer QoL more frequently than older women. Some other
recent studies on young adults with various cancers (Smith
et al. 2013, Geue et al. 2014), breast cancer (Arndt et al.
2004) and gynaecological cancer (Bifulco et al. 2012) sup-
port findings that younger women have lower scores on
several QoL dimensions, including fatigue, than older
women. In the latter comparison study between young and
midlife survivors of gynaecological cancers, Bifulco et al.
(2012) concluded that younger women (below age 45) were
more affected by fatigue and global health status. Further-
more, in a systematic review on health-related QoL in
younger breast cancer survivors (Howard-Anderson et al.
2012) and, more specifically, in a longitudinal study on
gynaecological cancers (Chan et al. (2001), the overall QoL
scores were lower for younger patients than for older. On
the contrary, other previous studies have shown the oppo-
site results, namely that QoL and fatigue outcome worsen
with age (Cella et al. 2002, Butt et al. 2010). Thus, under-
standing the relationship between age and fatigue has some
challenges. Although young age is generally associated with
health, vitality and long-term planning (Chan et al. 2001),
a possible interpretation is that younger patients find it
more difficult to accept a cancer diagnosis during early
adulthood and family establishment (Chan et al. 2001).
Younger women may also view cancer as a greater threat
to their lives than older patients (Arndt et al. 2004). Addi-
tionally, one may ask whether older women tend to regard
symptoms of fatigue as a normal process of ageing and thus
may underreport such symptoms. Older persons may also
consider physical health in different ways and assess their
health compared with their age peers (Arndt et al. 2004).
An overview on QoL in older breast cancer patients indi-
cates that older patients are perhaps better equipped men-
tally to deal with treatment (Ballinger & Fallowfield 2009).
Another explanation might be that younger women have
fewer coping strategies and resources that are needed to
manage a life-threatening disease (Arndt et al. 2004). Given
these results, it is essential that the QoL issues and fatigue
are given attention during treatment and follow-up for all
age groups and with a special focus on younger women.
In the present study, both depression and anxiety were
strongly linked to fatigue. Nearly all of the women with
Table 4 Logistic regression analysis of factors related to self-reported fatigue (n = 117). Tjur’s D = 029 (Tjur 2009)
Variables Odds ratio (adjusted) p-value (adjusted) Odds ratio (unadjusted) p-value (unadjusted)
Age 096 (092–099) 004 095 (092–098) 0002
Diagnosis 032 006
Cervical (ref.) 1 1
Uterine 077 (022–271) 034 (012–086)
Ovarian 178 (050–668) 083 (028–240)
Vulva 030 (001–460) 024 (001–279)
HADS 122 (112–134) <0001 122 (112–134) <0001
© 2014 The Authors. Journal of Clinical Nursing published by John Wiley & Sons Ltd
Journal of Clinical Nursing 7
Original article Fatigue and quality of life in women
depression (94%) and a majority of the women with anxi-
ety (78%) reported fatigue. This correlation between psy-
chological distress and fatigue is also found in several
studies concerning cancer in general (Brown & Kroenke
2009, Oh & Seo 2011), as well as in gynaecological cancer
studies (Ferrell et al. 2003, Liavaag et al. 2007, Vistad
et al. 2007, Harrington et al. 2010, Prue et al. 2010). A
systematic review by Oh and Seo (2011) indicates that
psychological distress seems to have a higher level of associ-
ation with cancer-related fatigue than the more physical
symptom distress. A systematic review by Brown and
Kroenke (2009) (sample size 12,103) confirms the associa-
tion of fatigue with depression and anxiety. The review
supported the conclusion of psychological correlation of
cancer-related fatigue, in line with some other previous
studies (Donovan & Ward 2005, Jacobsen et al. 2007).
However, the possible relationship and the direction of
causality (fatigue, anxiety and depression) are still unclear,
despite a recent increase in research interest. Studies with
longitudinal designs may give more knowledge about these
relationships.
For gynaecological cancer, a strong association between
cancer-related fatigue and psychological distress is
reported in several studies (Liavaag et al. 2007, Vistad
et al. 2007, Prue et al. 2010). Vistad et al. (2007) found
that there was an association between cancer-related fati-
gue and depression and anxiety in survivors after radia-
tion for cervical cancer. Liavaag et al. (2007) showed
that symptoms of anxiety and fatigue were more preva-
lent than those of depression in survivors after ovarian
cancers.
The women in our study who suffer from fatigue also
scored significantly lower on all eight domains of QoL, as
measured by the SF-36 questionnaire. Several other QoL
studies of gynaecological cancer have shown similar results
(Ahlberg et al. 2003, Holzner et al. 2003, Vistad et al.
2007, Liavaag et al. 2008, Arriba et al. 2010). The fatigued
women had lowest scores on the domains ‘physical role
function’, ‘emotional role function’ and ‘vitality/energy.’
This confirms that cancer-related fatigue has a strong
impact on women’s lives after treatment for gynaecological
cancer. It might decrease the women’s ability to carry out
everyday activities and may affect their quality of life. In
the qualitative study by Ferrell et al. (2003), the women
reported frustration and guilt regarding the impact of
fatigue on daily functioning. It is also likely that QoL and
particularly ‘role function’ and ‘vitality’ affect deeper layers
of a woman’s life and identity. Thus, fatigue seems to have
a greater impact on daily activities than other conditions
associated with cancer.
Limitations of the study
Questionnaire-collected data may have both advantages
and disadvantages. The difficulty level might influence
forced-choice answers in a negative way. The 120 women
who answered the questionnaire had agreed to participate
in an intervention study (n = 130). The results may not be
generalisable to the general population of gynaecological
cancer survivors and must be interpreted with caution. As
data were collected retrospectively, we do not know
whether quality of life and fatigue differences might have
existed in the groups before therapy. Furthermore, selection
bias will be present if the participants in this study have a
higher or lower quality of life than those who have refused
to participate.
Conclusion
The findings underscore the importance of and need for fol-
low-up in which screening for QoL, fatigue and symptom
management should be a standard procedure. Both somatic
and psychological aspects of fatigue must be emphasised.
Nurses, as well as other health personnel, should make
additional efforts to ask and educate patients about fatigue
and to provide self-care advice for coping with fatigue.
Relevance to clinical practice
Health personnel need to pay special attention to fatigue
and QoL issues during the entire trajectory of women diag-
nosed with gynaecological cancers, and likewise to the need
for screening, information, guidance and symptom manage-
ment. This concerns women of all age groups and particu-
larly younger women.
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